|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170.76 USD | +3.25% |
|
+0.31% | -3.50% |
| 20/01 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 20/01 | RBC Trims Price Target on Biogen to $217 From $220, Keeps Outperform Rating | MT |
| Capitalization | 2.43TCr 2.07TCr 1.92TCr 1.8TCr 3.35TCr 2,20800Cr 3.6TCr 22TCr 8.74TCr 1,05000Cr 9.1TCr 8.91TCr 3,83200Cr | P/E ratio 2025 * |
15.9x | P/E ratio 2026 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.6TCr 2.21TCr 2.05TCr 1.93TCr 3.59TCr 2,36300Cr 3.85TCr 24TCr 9.35TCr 1,12400Cr 9.74TCr 9.54TCr 4,10100Cr | EV / Sales 2025 * |
2.64x | EV / Sales 2026 * | 2.5x |
| Free-Float |
85.5% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Biogen Inc.
| 1 day | +3.10% | ||
| 1 week | +0.31% | ||
| Current month | -3.50% | ||
| 1 month | -2.79% | ||
| 3 months | +16.15% | ||
| 6 months | +38.43% | ||
| Current year | -3.50% |
| 1 week | 160.36 |  | 170.05 |
| 1 month | 160.36 | | 190.2 |
| Current year | 160.36 | | 190.2 |
| 1 year | 110.04 | | 190.2 |
| 3 years | 110.04 | | 319.76 |
| 5 years | 110.04 | | 468.55 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Jane Grogan
CTO | Chief Tech/Sci/R&D Officer | 59 | 02/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Caroline Dorsa
CHM | Chairman | 66 | 26/06/2023 |
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 4.3% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.25% | +0.31% | +20.47% | -41.82% | 2.43TCr | |
| +1.56% | -1.12% | +8.41% | +2.16% | 7.53TCr | |
| -2.45% | +87.30% | +87.30% | +87.30% | 6.02TCr | |
| -0.33% | +1.61% | -35.86% | -41.10% | 5.74TCr | |
| -0.62% | -1.62% | +39.56% | +231.60% | 5.72TCr | |
| +0.95% | -2.53% | +40.56% | +23.71% | 2.01TCr | |
| -0.60% | -7.44% | +166.34% | +91.88% | 1.85TCr | |
| -22.35% | -21.78% | +17.27% | +998.53% | 1.74TCr | |
| +7.12% | +13.41% | +28.23% | -76.63% | 1.68TCr | |
| +0.67% | -0.13% | +115.63% | +813.15% | 1.49TCr | |
| Average | -1.27% | -4.06% | +48.79% | +208.88% | 3.62TCr | |
| Weighted average by Cap. | -0.68% | -3.03% | +35.84% | +126.10% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 982.68Cr 837.54Cr 776.01Cr 729.84Cr 1.36TCr 89TCr 1.46TCr 8.96TCr 3.54TCr 43TCr 3.69TCr 3.61TCr 1,55200Cr | 932.32Cr 794.61Cr 736.24Cr 692.43Cr 1.29TCr 85TCr 1.38TCr 8.5TCr 3.36TCr 40TCr 3.5TCr 3.42TCr 1,47200Cr |
| Net income | 151.63Cr 129.23Cr 119.74Cr 112.61Cr 209.62Cr 14TCr 224.85Cr 1.38TCr 546.05Cr 6.56TCr 568.61Cr 556.95Cr 24TCr | 181.42Cr 154.63Cr 143.27Cr 134.74Cr 250.8Cr 17TCr 269.03Cr 1.65TCr 653.34Cr 7.85TCr 680.33Cr 666.38Cr 29TCr |
| Net Debt | 170.54Cr 145.35Cr 134.67Cr 126.66Cr 235.76Cr 16TCr 252.89Cr 1.55TCr 614.15Cr 7.38TCr 639.53Cr 626.41Cr 27TCr | -95Cr -81Cr -75Cr -71Cr -131.41Cr -8.65TCr -140.96Cr -866.48Cr -342.32Cr -4.11TCr -356.46Cr -349.15Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 169.84 $ | +2.70% | 3,03,103 |
| 20/26/20 | 165.38 $ | +0.58% | 18,79,947 |
| 16/26/16 | 164.42 $ | -2.46% | 18,16,538 |
| 15/26/15 | 168.57 $ | -0.44% | 15,62,727 |
| 14/26/14 | 169.31 $ | -5.04% | 36,35,883 |
Delayed Quote Nasdaq, January 21, 2026 at 08:59 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition